Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Doll

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Carcinogenesis|August 1, 1993
Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferasesD W Hein, M A Doll, T D Rustan, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
Prostate-specific human N-acetyltransferase 2 (NAT2) expression in the mouseM A Leff, P N Epstein, M A Doll, et al.
Cancer Research|September 1, 1996
Human N-acetylation of benzidine: role of NAT1 and NAT2T V Zenser, V M Lakshmi, T D Rustan, et al.
Toxicology Letters|December 1, 1992
Acetyltransferases and susceptibility to chemicalsD W Hein, T D Rustan, M A Doll, et al.
Journal of Biochemical and Molecular Toxicology|February 15, 2001
DNA adduct levels and absence of tumors in female rapid and slow acetylator congenic hamsters administered the rat mammary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridineA J Fretland, U S Devanaboyina, N A Nangju, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2000
N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal womenA C Deitz, W Zheng, M A Leff, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2000
Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphismsD W Hein, M A Doll, A J Fretland, et al.
Archives of Toxicology|January 1, 1993
Human acetylator genotype: relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosolJ W Rodriguez, W G Kirlin, R J Ferguson, et al.
Pharmacogenetics|April 13, 2000
Acetylator phenotype and genotype in patients infected with HIV: discordance between methods for phenotype determination and genotypeW M O'Neil, R K Drobitch, R D MacArthur, et al.
Mutation Research|May 12, 1997
Rodent models of the human acetylation polymorphism: comparisons of recombinant acetyltransferasesD W Hein, M A Doll, A J Fretland, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Carcinogenesis|August 1, 1993
Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferasesD W Hein, M A Doll, T D Rustan, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
Prostate-specific human N-acetyltransferase 2 (NAT2) expression in the mouseM A Leff, P N Epstein, M A Doll, et al.
Cancer Research|September 1, 1996
Human N-acetylation of benzidine: role of NAT1 and NAT2T V Zenser, V M Lakshmi, T D Rustan, et al.
Toxicology Letters|December 1, 1992
Acetyltransferases and susceptibility to chemicalsD W Hein, T D Rustan, M A Doll, et al.
Journal of Biochemical and Molecular Toxicology|February 15, 2001
DNA adduct levels and absence of tumors in female rapid and slow acetylator congenic hamsters administered the rat mammary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridineA J Fretland, U S Devanaboyina, N A Nangju, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2000
N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal womenA C Deitz, W Zheng, M A Leff, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2000
Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphismsD W Hein, M A Doll, A J Fretland, et al.
Archives of Toxicology|January 1, 1993
Human acetylator genotype: relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosolJ W Rodriguez, W G Kirlin, R J Ferguson, et al.
Pharmacogenetics|April 13, 2000
Acetylator phenotype and genotype in patients infected with HIV: discordance between methods for phenotype determination and genotypeW M O'Neil, R K Drobitch, R D MacArthur, et al.
Mutation Research|May 12, 1997
Rodent models of the human acetylation polymorphism: comparisons of recombinant acetyltransferasesD W Hein, M A Doll, A J Fretland, et al.
Pageof 4